First Time Loading...
S

Svas Biosana SpA
MIL:SVS

Watchlist Manager
Svas Biosana SpA
MIL:SVS
Watchlist
Price: 8.1 EUR 1.25% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

SVS Price Targets Summary
Svas Biosana SpA

Wall Street analysts forecast SVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SVS is 14.13 EUR with a low forecast of 13.64 EUR and a high forecast of 14.91 EUR.

Lowest
Price Target
13.64 EUR
68% Upside
Average
Price Target
14.13 EUR
74% Upside
Highest
Price Target
14.91 EUR
84% Upside
Svas Biosana SpA Competitors:
Price Targets
1501
Shanghai Kindly Medical Instruments Co Ltd
28% Upside
AMS
Advanced Medical Solutions Group PLC
32% Upside
XVIVO
Xvivo Perfusion AB
12% Upside
BLFS
BioLife Solutions Inc
31% Upside
TOPGLOV
Top Glove Corporation Bhd
8% Downside
8K7
UG Healthcare Corporation Ltd
82% Upside
KOSSAN
Kossan Rubber Industries Bhd
17% Downside
ATRI
Atrion Corp
28% Downside

Revenue
Forecast

Revenue Estimate
Svas Biosana SpA

For the last 4 years the compound annual growth rate for Svas Biosana SpA's revenue is 13%. The projected CAGR for the next 2 years is 3%.

13%
Past Growth
3%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Svas Biosana SpA

For the last 4 years the compound annual growth rate for Svas Biosana SpA's operating income is 13%. The projected CAGR for the next 2 years is 15%.

13%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Svas Biosana SpA

For the last 4 years the compound annual growth rate for Svas Biosana SpA's net income is 20%. The projected CAGR for the next 2 years is 19%.

20%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SVS's stock price target?
Price Target
14.13 EUR

According to Wall Street analysts, the average 1-year price target for SVS is 14.13 EUR with a low forecast of 13.64 EUR and a high forecast of 14.91 EUR.

What is Svas Biosana SpA's Revenue forecast?
Projected CAGR
3%

For the last 4 years the compound annual growth rate for Svas Biosana SpA's revenue is 13%. The projected CAGR for the next 2 years is 3%.

What is Svas Biosana SpA's Operating Income forecast?
Projected CAGR
15%

For the last 4 years the compound annual growth rate for Svas Biosana SpA's operating income is 13%. The projected CAGR for the next 2 years is 15%.

What is Svas Biosana SpA's Net Income forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Svas Biosana SpA's net income is 20%. The projected CAGR for the next 2 years is 19%.